1 / 4

Dr. Sheila Singh’s Laboratory

Dr. Sheila Singh’s Laboratory. Lab overview. Research Overview. Dr. Singh is a pediatric neurosurgeon and scientist This is a basic science laboratory with a strong clinical focus

eytan
Download Presentation

Dr. Sheila Singh’s Laboratory

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dr. Sheila Singh’s Laboratory Lab overview Research Overview Dr. Singh is a pediatric neurosurgeon and scientist This is a basic science laboratory with a strong clinical focus The overall research goal is to further elucidate the cancer stem cell hypothesis in brain tumours and to characterize the Brain Tumour Initiating Cell (BTIC) Our work includes tissue culture, molecular biology experiments and in vivo animal work • Operating since August 2007 • Located at the Stem Cell & Cancer Research Institute at McMaster Main Campus

  2. Cancer Stem Cell Hypothesis & the BTIC • Neural stem cells (found in brain) are tightly regulated & differentiate into normal cells of brain tissue • Cancer neural stem cells, by virtue of mutations, are dysregulated, & self renew & differentiate aberrantly, generating the abnormal cells that make up the brain cancer • The BTIC was identified by its cell surface protein expression of CD133 • In 2004, Singh et. al identified an abnormal stem cell (termed the BTIC) that drove the formation of brain tumours (Nature, 2004;432(7015):396-401) • BTIC’s represent a small fraction of the whole tumour, but these cells alone may be entirely responsible for the continued growth of the tumour • Clinical implications: therapies that focus on killing the bulk of the tumour may miss the rare stem cell fraction, allowing the tumour to continue to grow & potentially metastasize to form secondary tumours Nature. 2004;432(7015):281-2

  3. Tumor spheres of Anaplastic medulloblastoma in vitro 100x 200x 400x 0.05mm 0.05mm 0.05mm 0.05mm Tumor spheres of Metastatic Melanoma in vitro 200x 200x 100x 0.05mm 0.05mm 0.05mm 0.05mm

  4. BTIC Differentiation Undifferentiated spheres Day 7 Differentiated BTICs

More Related